Form D — Araceli Biosciences Inc.
0001975014-26-000004 · filed Nov 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Reported offering amount
- $4,500,000
- Reported amount sold
- $2,526,065
- Minimum investment
- $10,000
- Investors
- 4
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Araceli Biosciences Inc.
- CIK
- 1975014
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 7405 SW Tech Center Drive, Suite A160
TIGARD, OR 97223-8080 - Phone
- 971-713-2676
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matt Beaudet · Executive OfficerTigard, OR Find on LinkedIn ↗
-
Shawn MacDonald · Executive OfficerTigard, OR Find on LinkedIn ↗
-
William Cortelyou · DirectorTigard, OR Find on LinkedIn ↗
-
J. William Freytag · DirectorTigard, OR Find on LinkedIn ↗
-
Kirk Malloy · DirectorTigard, OR Find on LinkedIn ↗
-
Sean O'Neill · DirectorTirgard, OR Find on LinkedIn ↗
-
Samraat Raha · DirectorTigard, OR Find on LinkedIn ↗
-
Bruce Rhine · DirectorTigard, OR Find on LinkedIn ↗
-
Christine Ann Tsingos · DirectorTigard, OR Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗